Abstract
Pain in the cancer patient is often a consequence of tumor infiltration or compression of bone, soft tissue, peripheral nerve or spinal cord, or vascular occlusion [4,17]. The most effective management of cancer pain involves treatment of the tumor with surgery, radiation therapy, or chemotherapy, if possible. However, it is often necessary to manage pain with analgesic drugs prior to the introduction of specific antitumor therapy. Moreover, a significant percentage of patients will have chronic pain as a sequela of cancer treatment [42] (see table 1–1, Chapter 1, this volume). Finally, although invasive neurosurgical and anesthetic approaches to cancer pain management are indicated in a minority of patients, with a few exceptions (e.g., celiac ganglion blocks for pancreatic pain) they are not first-line treatments [16]. Therefore, the use of analgesic drugs has become the mainstay of acute and chronic cancer pain management, and narcotic analgesics are the drugs of choice for management of severe pain [4,15,55].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Amer S, Amer B (1985): Differential effects of epidural morphine in the treatment of cancer-related pain. Acta Anaesthesiol Scand 29: 32–36.
Beaver WT, Feise G (1976): Comparison of the analgesic effects of morphine, hydroxyzine and their combination in patients with post-operative pain. In: Bonica JJ, Albe-Fessard D (eds), Advances in Pain Research and Therapy. New York: Raven Press, pp 553–557.
Beaver WT, Wallenstein SL, Houde RW, et al. (1966): A comparison of the analgesic effect of methotrimeprazinc and morphine in patients with cancer. Clin Pharmacol Ther 7: 436–446.
Bonica, JJ (1985): The treatment of cancer pain: current status and future needs. In: Fields HL et al. (eds), Advances in Pain Research and Therapy, vol 9. New York: Raven Press, pp 589–616.
Botney M, Fields HL (1983): Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol 13: 160–164.
Brogden RN, Speigt TM, Avery GS (1973): Pentazocine: a review of pharmacological properties, therapeutics, efficacy and dependence. Drugs 5: 6–91.
Bromage PR (1985): Clinical aspects of intrathecal and epidural opiates. In: Fields HL et al. (eds), Advances in Pain Research and Therapy, vol 9. New York: Raven Press, pp 733–748.
Campbell CF, Matson JB, Weiler JM (1983): Continuous subcutaneous infusion of morphine for the pain of terminal malignancy. Ann Int Med 98: 51–52.
Chauvin M, Samii K, Schermann JM, et al. (1982): Plasma pharmacokinetics of morphine after i.m., extradural and intrathecal administration. Br J Anaesth 54: 843–848.
Cleeland CS, Cleeland LM, Dar R, et al. (1986): Factors in influencing physician management of cancer pain. Cancer 58: 796–800.
Cousins MJ, Mather LE (1984): Intrathecal and epidural administration of opioids. Anesthesiology 61: 276–310.
Coyle N, Mauskop A, Maggard J, et al. (1986): Continuous subcutaneous infusion of opiates in cancer patients with pain. One Nurs Forum 13: 53–57.
Feinmann C (1985): Pain relief by antidepressants: possible modes of action. Pain 23: 1–8.
Foley, KM (1981): Current issues in the management of cancer pain: Memorial Sloan-Kettering Cancer Center. In: Loreng NG (ed), New Approaches to Treatment of Chronic Pain. Nida Research Monograph 36: 169–181.
Foley KM (1982): The practical use of narcotic analgesics. Med Clin North Am 66: 1091–1104.
Foley, KM, Sundaresan N (1984): Management of cancer pain. In: Devita VT, Hellman S, Rosenberg SA (eds), Cancer: Principles and Practice of Oncology. Philadelphia: J.B. Lippincott Co., pp 1941–1961.
Foley KM (1985): The treatment of cancer pain. N Engl J Med 313: 84–95.
Foley KM (1985): Adjuvant analgesic drugs in cancer pain management. In: Aronoff GM (ed), Evaluation and Treatment of Chronic Pain. Baltimore-Munich: Urban and Schwarzenberg.
Forrest WH, Brown BW, Brown CR, et al. (1977): Dextroamphetamine with morphine for the treatment of postoperative pain. N Engl J Med 296: 712–715.
Fraser DG (1980): Intravenous morphine infusion for chronic pain. Ann lot Med 93: 781–782.
Graves D, Foster TS. Batenhorst RL, et al. (1983): Patient-controlled analgesia. Ann Int Med 99:360–366.
Greenberg HS, Taren J, Ensminger WD, Doan K (1982): Benefit from and tolerance to containuous intrathecal infusion of morphine for intractable cancer pain. J Neurosurg 57: 360–364.
Harris LS (1979): Cannabinoids as analgesics. In: Beers RF, Bassett EG (eds), New York: Raven Press. Mechanism of Pain and Analgesic Compounds.
Houde RW (1974): The use and misuse of narcotics in the treatment of chronic pain. Adv Neurol 4: 527–536.
Inturrisi CE, Max MB, Foley KM, et al. (1984): The pharmacokinetics of heroin in patients with chronic pain. N Engl J Med 210: 1213–1217.
Kaiko RF, Wallenstein SL, Rogers AG, et al. (1981): Analgesic and mood effects of heroin and morphine in cancer patients with postoperative pain. N Engl J Med 304: 1501–1505.
Kaiko RF, Wallenstein SL, Rogers AG, et al. (1982): Narcotics in the elderly. Med Clin North Am 66: 1079–1089.
Kaiko RF, Foley KM, Grabinski PY, et al. (1983): Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 13: 180–185.
Kanner RM, Foley KM (1981): Patterns of narcotic drug use in a cancer pain clinic. Ann NY Acad Sci 362: 161–172.
Kantor TG (1982): The control of pain by nonsteroidal anti-inflammatory drugs. Med Clin North Am 66: 1053–1059.
King JS, Gallant P, Myerson V, et al. (1976): The effects of anti-inflammatory agents on the responses and the sensitization of unmyelinated (C) fiber polymodal receptors. In: Zotterman Y (ed), Sensory Function of the Skin of Primates. Oxford: Pergamon Press, pp 441–461.
Leavens ME, Hill CS, Cech DA, et al. (1982): Intrathecal and intraventricular morphine for pain in cancer patients: initial study. J Neurosurg 56: 241–242.
Lenzi A, Galli G, Gandolfini M, et al. (1985): Intraventricular morphine in paraneoplastic painful syndrome of the cervicofacial region: experience in thirty-eight cases. Neurosurgery 17: 6–11.
Levin D, Cleeland CS, Dar R (1985): Public attitudes toward cancer pain. Cancer 56: 2337–2339.
Lobato RD, Madrid JL, Fatela LV, et al. (1985): Analgesia elicited by low-dose intraventricular morphine in terminal cancer patients. In: Fields HL et al. (eds), Advances in Pain Research and Therapy, vol 9. New York: Raven Press, pp 673–681.
Max MB, Inturrisi CE, Kaiko RF, et al. (1985): Epidural and intrathecal opiates: cerebrospinal fluid and plasma profiles in patients with chronic cancer pain. Clin Pharmacol Ther 38: 631–641.
Miser AW, Davis DM, Hughes CS, et al. (1983): Continuous subcutaneous infusions of morphine in children with cancer. Am J Dis Child 137: 383–385.
Miser AW, Miser JS, Clark BS (1980): Continuous intravenous infusion of morphine sulfate for control of severe pain in children with terminal malignancy. J Pediatr 5: 930–932.
Nahata MC, Miser AW, Miser JS, et al. (1984): Analgesic plasma concentrations of morphine in children with terminal malignancy receiving a continuous subcutaneous infusion of morphine sulfate to control severe pain. Pain 18: 109–114.
Neis A, Robinson DS, Friedman MJ, et al. (1977): Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiat 134: 790–793.
Newman RG (1983): The need to redefine “addiction”. N Engl J Med 308: 1096–1098.
Payne R, Foley KM (1984): Advances in the management of cancer pain. Cancer Treat Rep 68: 173–83.
Payne R (1986): The role of spinal opiates and opioid peptides in the management of cancer pain. Med Clin North Am (in press).
Perry S, Heidrich G (1982): Management of pain during debridement: a survey of U.S. burn units. Pain 13: 267–280.
Porter J, Jick H (1980): Addiction rare in patients treated with narcotics. N Engl J Med 302: 133.
Portenoy RK, Moulin DE, Rogers A, et al. (1986): I.V. infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer Treat Rep 70: 575–581.
Roquefeuil B, Benezech J, Blanchet P, et al. (1984): Intraventricular administration of morphine in patients with neoplastic intractable pain. Surg Neurol 21: 155–158.
Rotstein J, Good RA (1957): Steroid pseudorheumatism. Arch Int Med 99: 545–555.
Schlechter NE (1985): Pain and pain control in children. Curr Prob Pediatr 15: 1–67.
Spiegel K, Kalb R, Pasternak GW (1983): Analgesic activity of tricyclic antidepressants. Ann Neurol 13: 462–465.
Swerdlow M (1984): Anticonvulsant drugs and chronic pain. Clin Neuropharmacol 7: 51–82.
Tameson A, Hartvig P, Fagerlund C, et al. (1982): Patient-controlled analgesia: clinical experience. Acta Anesthesiol Scand (Suppl) 14: 157–160.
Twycross RG (1977): Value of cocaine in opiate-containing elixirs. Br Med J 2: 1348.
Twycross RG (1977): Choice of strong analgesic in terminal cancer: diamorphine or morphine? Pain 3: 93–104.
Twycross RG, Lack SA (1983): Symptom Control in Far Advanced Cancer: Pain Relief. London: Pitman Publishing.
Ventafridda V, Spoldi E, Caraceni A, et al. (1986): The importance of continuous subcutaneous morphine administration for cancer pain. The Pain Clinic 1: 47–55.
Waldmann CS, Eason JR, Rambohul E, et al. (1984): Serum morphine levels. A comparison between continuous subcutaneous infusion and continuous intravenous infusion in postoperative patients. Anaesthesia 39: 768–771.
Watson CP, Evans RJ, Reid K, et al. (1982): Amitriptyline vs. placebo in postherpetic neuralgia. Neurology 32: 671–73.
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
Payne, R. (1989). Oral and Parenteral Drug Therapy for Cancer Pain. In: Cancer Pain. Current Management of Pain, vol 3. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0875-1_2
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0875-1_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8223-5
Online ISBN: 978-1-4613-0875-1
eBook Packages: Springer Book Archive